Edit Entry

Gregory J. Tsongalis, BS, MS, PhD

Title(s):
Professor of Pathology and Laboratory Medicine

Additional Titles/Positions/Affiliations:
Director, Clinical Genomics and Advanced Technology (CGAT)

Department(s):
Pathology and Laboratory Medicine

Education:
Univ. of Massachusetts, Amherst, BS, 1984
Quinnipiac College, MHS, 1986
Univ. of Medicine and Dentistry of New Jersey, PhD 1990
Uniiv. of North Carolina, Chapel Hill, post-doctoral 1990-1994

Programs:
Norris Cotton Cancer Center
Program in Experimental and Molecular Medicine

Websites:
DHMC-CGAT.com

Contact Information:

Department of Pathology and Laboratory Medicine
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon NH 03756

Office: WTRB 4th floor
Phone: 603-650-5498
Fax: 603-650-6120
Email: Gregory.J.Tsongalis@hitchcock.org

Assistant: Amber Erskine
Asst. Phone: 603-650-6821
Asst. Email: amber.j.erskine@hitchcock.org


Professional Interests:

Development of advanced diagnostic technologies and disease biomarker discovery.

Grant Information:

01/2014-12/30/15; Molecular profiling of tumor and ctDNA, riends of NCCC Scholar $50,000

03/01/13-01/31/2018; 1P20GM104416, Investigator / 2% COBRE Center for Molecular Epidemiology, Federal Direct Costs: $1,793,732


Selected Publications:

 

Rapid EGFR mutation testing in lung cancer tissue samples using a fully automated system and single-use cartridge.
Al-Turkmani MR, Suriawinata MA, Deharvengt SJ, Green DC, Black CC, Shirai K, Dragnev KH, Tsongalis GJ
Pract Lab Med. 2020 May;20:e00156. doi: 10.1016/j.plabm.2020.e00156. Epub 2020 Mar 2.
PMID: 32181314

Feasibility of Brigade-Style, Multiphasic Cancer Screening in Rural Honduras.
Lyons KD, Kennedy LS, Larochelle EPM, Tsongalis GJ, Reyes HS, Zuniga-Moya JC, Chamberlin MD, Bruce ML, Bejarno S
JCO Glob Oncol. 2020 Mar;6:453-461. doi: 10.1200/JGO.19.00396.
PMID: 32160013

A case of molecularly confirmed BAP1 inactivated melanocytic tumor with retention of immunohistochemical expression: A confounding factor.
Linos K, Atkinson AE, Yan S, Tsongalis GJ, Lefferts JA
J Cutan Pathol. 2019 Dec 31; doi: 10.1111/cup.13642. Epub 2019 Dec 31.
PMID: 31891422

MicroRNAs in graft-versus-host disease: a review of the latest data.
Newmarch M, Kostantin E, Tsongalis GJ, Guimond M, Roy J, De Guire V, Ahmad I
Bone Marrow Transplant. 2019 Dec 3; doi: 10.1038/s41409-019-0764-1. Epub 2019 Dec 3.
PMID: 31796872

BRAF V600E mutations are not an oncogenic driver of solitary xanthogranuloma and reticulohistiocytoma: Testing may be useful in screening for Erdheim-Chester disease.
Hoyt BS, Yan S, Linos KD, Momtahen S, Sriharan A, Tran TN, Tsongalis GJ, O'Meara RR, Green DC, LeBlanc RE
Exp Mol Pathol. 2019 Dec;111:104320. doi: 10.1016/j.yexmp.2019.104320. Epub 2019 Oct 19.
PMID: 31639332

Third-Generation Sequencing in the Clinical Laboratory: Exploring the Advantages and Challenges of Nanopore Sequencing.
Petersen LM, Martin IW, Moschetti WE, Kershaw CM, Tsongalis GJ
J Clin Microbiol. 2019 Dec 23;58(1) pii: e01315-19. doi: 10.1128/JCM.01315-19. Epub 2019 Dec 23.
PMID: 31619531

How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market.
Bonneau E, Neveu B, Kostantin E, Tsongalis GJ, De Guire V
EJIFCC. 2019 Jun;30(2):114-127. Epub 2019 Jun 24.
PMID: 31263388

Screening for Human Papillomavirus in a Low- and Middle-Income Country.
Atkinson AE, Mandujano CAM, Bejarano S, Kennedy LS, Tsongalis GJ
J Glob Oncol. 2019 May;5:JGO1800233. doi: 10.1200/JGO.18.00233.
PMID: 31050922

Pancreatic cyst fluid harboring a KRAS mutation.
Al-Turkmani MR, Gordon SR, Smith KD, Tsongalis GJ, Liu X
Cold Spring Harb Mol Case Stud. 2019 Apr;5(2) pii: a003830. doi: 10.1101/mcs.a003830. Epub 2019 Apr 1.
PMID: 30936197

Design of peptide nucleic acid probes on plasmonic gold nanorods for detection of circulating tumor DNA point mutations.
Tadimety A, Zhang Y, Kready KM, Palinski TJ, Tsongalis GJ, Zhang JXJ
Biosens Bioelectron. 2019 Apr 1;130:236-244. doi: 10.1016/j.bios.2019.01.045. Epub 2019 Jan 29.
PMID: 30769288

View more publications on PubMed